Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

Yamato M

Yamato M
Institute of Advanced Biomedical Engineering and Science,
8-1 Kawada-cho, Shinjukuku, Tokyo 162-8666
Japan

Publications
  • Commentary
    Diverse Approval Systems for Autologous Human Cells and Tissue Products
    Author(s): Yano K, Watanabe N and Yamato M Yano K, Watanabe N and Yamato M

    Human cells and tissue products are newly categorized products which are containing, consisting of, or derived from cells or tissue that are intended for implantation, transplantation, infusion, or transfer into human recipient. The human cells and tissue products are divided as autologous or allogeneic based on their origin. Since another product fabricated with patient?s own limbal epithelial stem cells, was approved as conditional approval for therapeutic indication which is the treatment of adult patients with moderate to severe limbal stem cell deficiency in the European Union, we reviewed the European Public Assessment Report. Of the ten autologous human cells and tissue products, the five products were evaluated using the clinical data with clinical experiences as well as retrospective observatory study or registry, or open clinical trials with small subjects, although for the res.. View More»
    DOI: 10.4172/2167-7700.1000157

    Abstract PDF

Relevant Topics

Top